SCHEMBL369615

SCHEMBL369615

COc1cccc(CN2CCC(Br)C(=O)c3c[nH]nc32)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
SIGMAR1 Q99720 2/20 0.44
OPRM1 P35372 1/20 0.43
CMA1 P23946 1/20 0.43
ROCK2 O75116 2/20 0.42
ROCK1 Q13464 1/20 0.42
KDM4E B2RXH2 3/20 0.42
PKM P14618 1/20 0.42
MAPT P10636 1/20 0.42
ACHE P22303 2/20 0.42
KMT2A Q03164 1/20 0.42
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM3 P20309 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
TNIK Q9UKE5 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8562273 0.83 SIGMAR1 (0.55) ALDH1A1SIGMAR1OPRM1CMA1KDM4E
SCHEMBL8562278 0.83 SIGMAR1 (0.55) ALDH1A1SIGMAR1OPRM1CMA1KDM4E
SCHEMBL6828052 0.70 SIGMAR1 (0.56) SIGMAR1CMA1ROCK2PKMKMT2A
SCHEMBL28961034 0.69 KMT2A (0.53) ALDH1A1SIGMAR1CMA1KDM4EPKM
SCHEMBL16242663 0.69 GRIN1 (0.42) ROCK2
SCHEMBL4004474 0.69 MEN1 (0.67) ALDH1A1SIGMAR1CMA1KDM4EPKM
SCHEMBL8562128 0.69 GAA (0.56) ALDH1A1SIGMAR1CMA1LMNAGAA
SCHEMBL8562132 0.69 GAA (0.56) ALDH1A1SIGMAR1CMA1LMNAGAA
SCHEMBL30527306 0.69 MEN1 (0.67) ALDH1A1SIGMAR1CMA1KDM4EPKM
SCHEMBL21328463 0.68 ROCK2 (0.57) ALDH1A1CMA1ROCK2ROCK1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9765091-B2 Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors ADDEX PHARMA S.A. (CH) 2017-09-19 US disclosed
EP-2592932-B1 NOVEL TETRAHYDROPYRAZOLO[3,4-B]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2016-01-20 EP disclosed
US-20130267499-A1 NOVEL TETRAHYDROPYRAZOLO [3,4-b] AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2013-10-10 US disclosed
EP-2592932-A2 NOVEL TETRAHYDROPYRAZOLO[3,4-B]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Addex Pharma SA (CH) 2013-05-22 EP disclosed
WO-2012009001-A2 NOVEL TETRAHYDROPYRAZOLO[3,4-B]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130267499-A1 NOVEL TETRAHYDROPYRAZOLO [3,4-b] AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM4, GRM1, GRIK4 ALDH1A1 3774/4885SIGMAR1 325/4885OPRM1 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.